Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing
Reexamination Certificate
2006-10-03
2006-10-03
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
C424S185100, C424S192100, C435S069100, C530S350000
Reexamination Certificate
active
07115260
ABSTRACT:
Human ICE LAP-6 polypeptides and DNA (RNA) encoding such ICE LAP-6 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such ICE LAP-6 for the treatment of a susceptibility to viral infection, tumorogenesis and to diseases and defects in the control embryogenesis and tissue homeostasis, and the nucleic acid sequences described above may be employed in an assay for ascertaining such susceptibility. Antagonists against such ICE LAP-6 and their use as a therapeutic to treat Alzheimer's disease, Parkinson's disease, rheumatoid arthritis, septic shock, sepsis, stroke, chronic inflammation, acute inflammation, CNS inflammation, osteoporosis, ischemia reperfusion injury, cell death associated with cardiovascular disease, polycystic kidney disease, apoptosis of endothelial cells in cardiovascular disease, degenerative liver disease, MS, ALS, cererbellar degeneration, ischemic injury, myocardial infarction, AIDS, myelodysplastic syndromes, aplastic anemia, male pattern baldness, and head injury damage are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the interleukin-1 beta converting enzyme apoptosis proteases and for detecting altered levels of the polypeptide in a host.
REFERENCES:
patent: 6010878 (2000-01-01), Dixit et al.
patent: 6294169 (2001-09-01), Dixit et al.
patent: WO-93/00353 (1993-01-01), None
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz, et al., (ed.), Birkhauser, Boston, MA, pp. 491-495.
Attwood et al., The babel of bioinformatics, Oct. 2000, Science 290 (5491): 471-473.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Duan et al., “ICE-LAP3, a Novel Mammalian Homologue of the Caenorhabditis elegans Cell Death Protein Ced-3 Is Activated during Fas- and Tumor Necrosis Factor-induced Apoptosis,” The Journal of Biological Chemistry, vol. 271 (3), pp. 1621-1625 (1996).
Fernandes-Alnemri et al., “Mch3, a Novel Human Apoptotic Cysteine Protease Highly Related to CPP32,” Cancer Research, vol. 55, pp. 6045-6052 (1995).
GenBank Accession No. H39637, Aug. 4, 1995, Hillier, L. et al., Homo Sapiens cDNA Clone 1819835.
GenBank Accession No. T97582, Apr. 16, 1995, Hillier, L. et al., Homo Sapiens cDNA Clone 1216935.
Duan et al., “ICE-LAP6, a Novel Member of the ICE/CED-3 Gene Family, Is Activated by the Cytotoxic T Cell Protease Granzyme B,” The Journal of Biological Chemistry, vol. 271 (28), pp. 16720-16724 (1996).
Srinivasula et al., “The Ced-3/Interleukin 1-beta Converting Enzyme-like Homolog Mch6 and the Lamin-cleaving Enzyme Mch2-alpha Are Substrates for the Apoptotic Mediator CPP32,” The Journal of Biological chemistry, vol. 271 (43), pp. 27099-27106 (1996).
Orkin et al., “Report and recommendations of the panel to assess the NIH investment in research on gene therapy,” issued by the U.S. Nation Institutes of Health, Dec. 1995.
Ngo et al., “Computational complexity, protein structure prediction, and the Levinthal paradox,” The Protein Folding Problem and Teriary Structure Prediction, Merx et al., Birkhauser Boston: Boston MA, pp. 433 and 492-495 (1994).
Fernandes-Alnemri et al., “CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1 beta converting enzyme,” Journal of Biological Chemistry, vol. 269 (49), pp. 30761-30764 (1994).
Cryns et al., “The cutting edge: caspases in apoptosis and disease,” pp. 177-210, When Cells Die, eds. Lockshin et al. New York: Willey-Liss, Inc. (1998).
Pa Henkart, “ICE family proteases: mediators of all apoptotic cell death?,” Immunity vol. 4, pp. 195-201, (1996).
Alnemri et al., “Cloning and Expression of four novel isoforms of human interleukin-1beta converting enzyme with different apoptotic activities,” Journal of Biological Chemistry, Mar. 3, 1995, vol. 270, No. 9, pp. 4312-4317.
Tewari et al., “Yama/CPP32beta, a mammalian homolog of ced-3 is a crmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase,” Cell, Jun. 2, 1995, vol. 81, No. 5, pp. 801-809.
Wang et al., “Ich-1, an ICE/ced-3 related gene, encodes both positive and negative regulators of programmed cell death,” Cell Sep. 9, 1994, vol. 78, pp. 739-750.
Thornberry et al., “Interleukin-1beta-converting enzyme and related proteases as potential targets in inflammation and apoptosis,” Perspectives in Drug Discovery and Design, Jul. 1995, vol. 2, No. 3, pp. 389-399.
Kamens et al, “Identification and characterization of ICH-2, a novel member of the interleukin-1beta-converting family of cysteine proteases,” Journal of Biological Chemistry, Jun. 23, 1995, vol. 270, No. 25, pp. 15250-15256.
Dixit Vishva M.
He Wei-Wu
Kikly Kristine K.
Ruben Steven M.
Chan Christina
Human Genome Sciences Inc.
Human Genome Sciences Inc.
Huynh Phuong
SmithKline Beecham Corporation
LandOfFree
Interleukin-1β converting enzyme like apoptotic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-1β converting enzyme like apoptotic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-1β converting enzyme like apoptotic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3621214